$RGLS Regulus Therapeutics Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Regulus Therapeutics Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Regulus Therapeutics Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Regulus Therapeutics Inc. for free.

CIK Number: 0001505512
IRS Number: 264738379
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RGLS
Company Address: 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO 92121
Phone number: 858-202-6300

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The firm is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded on September 5, 2007 and is headquartered in San Diego, CA.

Market Capitalization: $72.77M
Prev close: $1.40
Average Daily Volume: 772,552
Days Low: $1.35
Year Low: $1.05
Year High: $8.90

Regulus Therapeutics Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 16 2021RGLSRegulus Therapeuti ...Hagan Joseph PPresident and CEOOption ExerciseC0.007,58500
Apr 16 2021RGLSRegulus Therapeuti ...Hagan Joseph PPresident and CEOBuyC0.0075,8500320,478244.6 K to 320.5 K (+31.01 %)
Feb 17 2021RGLSRegulus Therapeuti ...Aker Christopher RaySr. VP & General Co ...SellS1.728281,42442,61443.4 K to 42.6 K (-1.91 %)
Feb 17 2021RGLSRegulus Therapeuti ...Hagan Joseph PPresident and CEOSellS1.724,1447,128485,756489.9 K to 485.8 K (-0.85 %)
Feb 05 2021RGLSRegulus Therapeuti ...CALSADA CRISPINAChief Financial Off ...Option ExerciseA1.59150,000238,500150,000
Feb 05 2021RGLSRegulus Therapeuti ...Aker Christopher RaySr. VP & General Co ...Option ExerciseA1.59180,000286,200180,000
Jan 27 2021RGLSRegulus Therapeuti ...Huang Alice Shih-houDirectorOption ExerciseA1.5580,000124,00080,000
Dec 07 2020RGLSRegulus Therapeuti ...Walker Paul Edward10% OwnerOption ExerciseP0.00258,7070258,707
Dec 07 2020RGLSRegulus Therapeuti ...Walker Paul Edward10% OwnerOption ExerciseP0.755,239,2543,910,5795,239,254
Dec 07 2020RGLSRegulus Therapeuti ...Walker Paul Edward10% OwnerBuyP0.624,398,6022,735,9306,451,0562.1 M to 6.5 M (+214.31 %)
Dec 07 2020RGLSRegulus Therapeuti ...Sonsini Peter W.10% OwnerOption ExerciseP0.00258,7070258,707
Dec 07 2020RGLSRegulus Therapeuti ...Sonsini Peter W.10% OwnerOption ExerciseP0.755,239,2543,910,5795,239,254
Dec 07 2020RGLSRegulus Therapeuti ...Sonsini Peter W.10% OwnerBuyP0.624,398,6022,735,9306,451,0562.1 M to 6.5 M (+214.31 %)
Dec 07 2020RGLSRegulus Therapeuti ...SANDELL SCOTT D10% OwnerOption ExerciseP0.00258,7070258,707
Dec 07 2020RGLSRegulus Therapeuti ...SANDELL SCOTT D10% OwnerOption ExerciseP0.755,239,2543,910,5795,239,254

View all Regulus Therapeutics Inc. insider transactions.